Jacobs Levy Equity Management
VSTM icon

Jacobs Levy Equity Management’s Verastem VSTM Stock Holding History

Jacobs Levy Equity Management’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,103
Closed -$119K – 1045
2024
Q1 		$119K Hold
10,103
– – ﹤0.01% 910
2023
Q4 		$82.2K Hold
10,103
– – ﹤0.01% 959
2023
Q3 		$82.1K Hold
10,103
– – ﹤0.01% 945
2023
Q2 		$75.2K Sell
10,103
-35,432
-78% -$246K ﹤0.01% 951
2023
Q1 		$227K Buy
45,535
+21,174
+87% +$134K ﹤0.01% 899
2022
Q4 		$118K Sell
24,361
-7,199
-23% -$35.3K ﹤0.01% 925
2022
Q3 		$322K Buy
+31,560
New +$440K ﹤0.01% 882
2022
Q1 		– Sell
-16,423
Closed -$404K – 1094
2021
Q4 		$404K Sell
16,423
-6,169
-27% -$195K ﹤0.01% 862
2021
Q3 		$835K Hold
22,592
– – 0.01% 780
2021
Q2 		$1.1M Sell
22,592
-54,667
-71% -$2.28M 0.01% 722
2021
Q1 		$2.29M Buy
77,259
+4,457
+6% +$125K 0.02% 569
2020
Q4 		$1.86M Buy
72,802
+42,885
+143% +$862K 0.02% 589
2020
Q3 		$434K Buy
29,917
+27,834
+1,336% +$461K ﹤0.01% 827
2020
Q2 		$43K Buy
+2,083
New +$55.1K ﹤0.01% 1024
2019
Q1 		– Sell
-1,433
Closed -$58K – 1049
2018
Q4 		$58K Sell
1,433
-3,920
-73% -$239K ﹤0.01% 954
2018
Q3 		$466K Sell
5,353
-7,905
-60% -$786K 0.01% 791
2018
Q2 		$1.09M Buy
13,258
+125
+1% +$7.65K 0.02% 646
2018
Q1 		$470K Buy
13,133
+817
+7% +$31.6K 0.01% 787
2017
Q4 		$454K Sell
12,316
-1,050
-8% -$47.4K 0.01% 773
2017
Q3 		$754K Sell
13,366
-5,242
-28% -$247K 0.01% 638
2017
Q2 		$487K Buy
18,608
+4,878
+36% +$124K 0.01% 704
2017
Q1 		$341K Sell
13,730
-3,300
-19% -$52.4K 0.01% 708
2016
Q4 		$229K Sell
17,030
-7,133
-30% -$106K ﹤0.01% 812
2016
Q3 		$386K Sell
24,163
-942
-4% -$15.2K 0.01% 759
2016
Q2 		$392K Sell
25,105
-5,726
-19% -$101K 0.01% 819
2016
Q1 		$585K Buy
+30,831
New +$495K 0.01% 695

Other funds holding VSTM

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management's VSTM Position: Q2 2024 in Review

Jacobs Levy Equity Management sold out of Verastem (VSTM) in Q2 2024, closing a stake of 10,103 shares — an estimated $119K sold.

Jacobs Levy Equity Management first reported a position in VSTM in Q1 2016 and held it in 26 quarters. The position peaked at $2.29M in Q1 2021. 68 funds tracked by Wall St. Rank hold VSTM as of Q2 2024.

  • Jacobs Levy Equity Management reported no remaining Verastem position as of Q2 2024 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 10,103 Verastem shares in Q2 2024, an estimated $119K.
  • Jacobs Levy Equity Management first reported a position in Verastem in Q1 2016 and held it in 26 quarters.
  • Jacobs Levy Equity Management's Verastem position peaked at $2.29M in Q1 2021.
  • 68 funds tracked by Wall St. Rank held Verastem as of Q2 2024.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2024, filed 14 Aug 2024.